| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2022 | Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine | C.-Y. Wu ; C.-W. Cheng; C.-C. Kung; K.-S. Liao; J.-T. Jan ; C. Ma ; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 119(9), e2119995119 | |||
| 2021 | Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection | J.-T. Jan; T.-J. R. Cheng; Y.-P. Juang; H.-H. Ma; Y.-T. Wu; W.-B. Yang; C.-W. Cheng; X. Chen; T.-H. Chou; J.-J. Shie; W.-C. Cheng; R.-J. Chein ; S.-S. Mao; P.-H. Liang; C. Ma; S.-C. Hung; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 118(5), e2021579118 | |||
| 2023 | Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA) | C.-W. Cheng; C.-Y. Wu ; S.-W. Wang; J.-Y. Chen; C.-C. Kung; K.-S. Liao; C.-H. Wong | Proceedings of the National Academy of Sciences of the United States of America 120(49), e2314392120 |
